Drug Type Small molecule drug |
Synonyms PD 0299685, PD-299685, PF-299685 |
Target |
Action blockers |
Mechanism CACNA2D1 blockers(Voltage-gated calcium channel alpha2/delta subunit 1 blockers) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cystitis, Interstitial | Phase 2 | United States | 01 Aug 2008 | |
Cystitis, Interstitial | Phase 2 | Canada | 01 Aug 2008 | |
Cystitis, Interstitial | Phase 2 | Denmark | 01 Aug 2008 | |
Cystitis, Interstitial | Phase 2 | Finland | 01 Aug 2008 | |
Cystitis, Interstitial | Phase 2 | France | 01 Aug 2008 | |
Cystitis, Interstitial | Phase 2 | Germany | 01 Aug 2008 | |
Flushing | Phase 2 | United States | 01 Aug 2006 | |
Flushing | Phase 2 | Australia | 01 Aug 2006 | |
Flushing | Phase 2 | Canada | 01 Aug 2006 | |
Flushing | Phase 2 | France | 01 Aug 2006 |